CA2561160A1 - Novel process - Google Patents
Novel process Download PDFInfo
- Publication number
- CA2561160A1 CA2561160A1 CA002561160A CA2561160A CA2561160A1 CA 2561160 A1 CA2561160 A1 CA 2561160A1 CA 002561160 A CA002561160 A CA 002561160A CA 2561160 A CA2561160 A CA 2561160A CA 2561160 A1 CA2561160 A1 CA 2561160A1
- Authority
- CA
- Canada
- Prior art keywords
- 6alkyl
- formula
- hydroxy
- amino
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 19
- -1 C1-6alkyl-oxy Chemical group 0.000 claims description 18
- 229910052736 halogen Inorganic materials 0.000 claims description 16
- 150000002367 halogens Chemical class 0.000 claims description 16
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 125000001246 bromo group Chemical group Br* 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000012345 acetylating agent Substances 0.000 claims description 7
- 239000011968 lewis acid catalyst Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 5
- 239000012346 acetyl chloride Substances 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- 125000002346 iodo group Chemical group I* 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 claims description 3
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 2
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims 2
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 7
- 239000000543 intermediate Substances 0.000 abstract description 3
- 208000020401 Depressive disease Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 239000004000 serotonin 1B antagonist Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 description 11
- 150000001721 carbon Chemical class 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 125000004429 atom Chemical group 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 150000004777 chromones Chemical class 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OONDYRNMURZSPQ-UHFFFAOYSA-N 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone Chemical compound CC(=O)C1=CC(F)=CC(Br)=C1O OONDYRNMURZSPQ-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 238000004774 atomic orbital Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- MEYRABVEYCFHHB-UHFFFAOYSA-N 2-bromo-4-fluorophenol Chemical compound OC1=CC=C(F)C=C1Br MEYRABVEYCFHHB-UHFFFAOYSA-N 0.000 description 1
- JRMAQQQTXDJDNC-UHFFFAOYSA-M 2-ethoxy-2-oxoacetate Chemical compound CCOC(=O)C([O-])=O JRMAQQQTXDJDNC-UHFFFAOYSA-M 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- NZIUIJUSQQFSFK-UHFFFAOYSA-N Br.Cl.Cl.Cl.Cl Chemical compound Br.Cl.Cl.Cl.Cl NZIUIJUSQQFSFK-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- MWVVPORMCGMIJL-UHFFFAOYSA-N [Na+].[Na+].CC[O-].CC(C)[O-] Chemical compound [Na+].[Na+].CC[O-].CC(C)[O-] MWVVPORMCGMIJL-UHFFFAOYSA-N 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- NIYBSDSIFPBWGM-UHFFFAOYSA-N ethyl 8-bromo-6-fluoro-4-oxochromene-2-carboxylate Chemical compound FC1=CC(Br)=C2OC(C(=O)OCC)=CC(=O)C2=C1 NIYBSDSIFPBWGM-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical class OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyrane Compounds (AREA)
Abstract
Provided herein are novel processes for the preparation of intermediates that may be useful in the preparation of 5-Ht1b receptor antagonist useful in the treatment of depression, anxiety and other related diseases. The present processes may offer improved yields, purity, ease of preparation and isolation of intermediates and final product and more industrially useful reaction conditions and workability.
Description
_1_ FIELD OF INVENTION
The present invention provides a novel process for the preparation of chromone compounds having the general formula I:
Rz wherein Rl is selected from H, C1_loallcyl, halogen, amino, Cl_6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, CI_6allcyl, halogen, hydroxy, amino, CI_6alkyl-amino, CI_6alkyl-carbonyl, CI_6alkyl-oxy and CI_6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
BACKC"rROITND OF THE INVENTION
The present invention relates to the preparation of chromone compounds that may be useful in the manufacture of potentially potent orally active 5-Httb receptor antagonist, useful in the treatment of depression, anixiety and other related diseases. An example of such a preparation is as follows:
1. DMADC 1. H2S04 \ E~ Nropanol F \ OH 2. EtOH F \
/ OH ~ ~ / O ~ OH ~ ~ / O ~ OEt 2. NaOH/H20 Br Br O Br O
II
While this preparation leads to the chromone compound it also suffers from several drawbacks, making its viability for commercial production doubtful.
Applicants provide a process for the preparation of chromone compounds of formula I
that unexpectedly and surprisingly provide improvements in product yields, cost, energy consumption, reduction in the number of synthetic steps, improved scale up conditions, and the like.
IJESCRIPTION OF THE INVENTION
Provided herein is a process for preparing compounds of formula I:
RZ
I
wherein Rl is selected from H, C1_ioalkyl, halogen, amino, C1_6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, Cl_6alkyl, halogen, hydroxy, amino, Cl_6alkyl-amino, CI_6alkyl-carbonyl, Cl_6allcyl-oxy and Cl_6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising A) heating a mixture of a compound of formula Va:
The present invention provides a novel process for the preparation of chromone compounds having the general formula I:
Rz wherein Rl is selected from H, C1_loallcyl, halogen, amino, Cl_6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, CI_6allcyl, halogen, hydroxy, amino, CI_6alkyl-amino, CI_6alkyl-carbonyl, CI_6alkyl-oxy and CI_6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
BACKC"rROITND OF THE INVENTION
The present invention relates to the preparation of chromone compounds that may be useful in the manufacture of potentially potent orally active 5-Httb receptor antagonist, useful in the treatment of depression, anixiety and other related diseases. An example of such a preparation is as follows:
1. DMADC 1. H2S04 \ E~ Nropanol F \ OH 2. EtOH F \
/ OH ~ ~ / O ~ OH ~ ~ / O ~ OEt 2. NaOH/H20 Br Br O Br O
II
While this preparation leads to the chromone compound it also suffers from several drawbacks, making its viability for commercial production doubtful.
Applicants provide a process for the preparation of chromone compounds of formula I
that unexpectedly and surprisingly provide improvements in product yields, cost, energy consumption, reduction in the number of synthetic steps, improved scale up conditions, and the like.
IJESCRIPTION OF THE INVENTION
Provided herein is a process for preparing compounds of formula I:
RZ
I
wherein Rl is selected from H, C1_ioalkyl, halogen, amino, C1_6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, Cl_6alkyl, halogen, hydroxy, amino, Cl_6alkyl-amino, CI_6alkyl-carbonyl, Cl_6allcyl-oxy and Cl_6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising A) heating a mixture of a compound of formula Va:
Va, and an acetylating agent in the presence of a Lewis acid catalyst at a temperature and for a time effective to give compounds of formula Vb:
~1 " "9 B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc:
Vc, and C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula I.
In another embodiment, R1 is, independently, ~I, C~-C6 alkyl, halogen, hydroxyl, methoxy or cyano. In a more particular embodiment Rl is, independently, hydrogen or fluoro.
In another embodiment, L is a displaceable group. In another embodiment L is a displaceable group selected from bromo, chloro, fluoro or iodo. In a more particular embodiment L is bromo.
~1 " "9 B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc:
Vc, and C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula I.
In another embodiment, R1 is, independently, ~I, C~-C6 alkyl, halogen, hydroxyl, methoxy or cyano. In a more particular embodiment Rl is, independently, hydrogen or fluoro.
In another embodiment, L is a displaceable group. In another embodiment L is a displaceable group selected from bromo, chloro, fluoro or iodo. In a more particular embodiment L is bromo.
In another embodiment, Ra is selected from H, Cl_6alkyl, halogen, hydroxy, amino or Cl_6allcyl-oxy optionally substituted by one or more groups selected from halogen, amino and hydroxy. In a more particular embodiment, R2 is selected from H, C1_6alkyl, C1_6allcyl-oxy or hydroxy.
If necessary a number of different bases and solvents can be used for the above process. The above process may further include a step for separating, filtering or washing compounds that may be carried out in any number of ways known in the art.
In another embodiment, heating the compound of formula Va, the acetylating agent and the catalyst may be conducted at a temperature and for a time effective to provide compound Vb. In a more particular embodiment, the heating of formula Va, the acetylating agent and the catalyst may be conducted at a temperature between about 130 and about 135°C
for about 1 to 2 hours.
In another embodiment, the acetylating agent are those functional derivatives of carboxylic acids that contain an acyl group and that can undergo nucleophilic substitution. For example, suitable acetylating agents include acetic acid, acetic anhydride, acetamide, acetyl chloride, acetyl bromide and ethyl acetate. In a more particular embodiment, the acetylating agent may be acetyl chloride.
In another embodiment, the Lewis acid catalyst may be selected from aluminum chloride, zirconium tetrachloride, bromide tetrachloride, HF and phosphoric acid. In a more particular embodiment, the Lewis acid catalyst may be selected from aluminum chloride or zirconium tetrachloride. In particular, the Lewis acid catalysts may be aluminum chloride.
In another embodiment the Lewis acid catalyst may be added in portions. In particular, the Lewis acid catalyst may be added in two portions.
In another embodiment, the pH level may be adjusted. In another embodiment, the pH
level may be adjusted to about 7.
If necessary a number of different bases and solvents can be used for the above process. The above process may further include a step for separating, filtering or washing compounds that may be carried out in any number of ways known in the art.
In another embodiment, heating the compound of formula Va, the acetylating agent and the catalyst may be conducted at a temperature and for a time effective to provide compound Vb. In a more particular embodiment, the heating of formula Va, the acetylating agent and the catalyst may be conducted at a temperature between about 130 and about 135°C
for about 1 to 2 hours.
In another embodiment, the acetylating agent are those functional derivatives of carboxylic acids that contain an acyl group and that can undergo nucleophilic substitution. For example, suitable acetylating agents include acetic acid, acetic anhydride, acetamide, acetyl chloride, acetyl bromide and ethyl acetate. In a more particular embodiment, the acetylating agent may be acetyl chloride.
In another embodiment, the Lewis acid catalyst may be selected from aluminum chloride, zirconium tetrachloride, bromide tetrachloride, HF and phosphoric acid. In a more particular embodiment, the Lewis acid catalyst may be selected from aluminum chloride or zirconium tetrachloride. In particular, the Lewis acid catalysts may be aluminum chloride.
In another embodiment the Lewis acid catalyst may be added in portions. In particular, the Lewis acid catalyst may be added in two portions.
In another embodiment, the pH level may be adjusted. In another embodiment, the pH
level may be adjusted to about 7.
In another embodiment, one of the carbonyl groups forming the dicarbonyl compound may be an ester. For example, suitable dicarbonyl compounds include Pyruvate or glyoxylate esters, methylglyoxal, and CI_4oxalate. In particular, the dicarbonyl compound may be ethyl oxalate.
In another embodiment, reacting the compound of formula Vb with a dicarbonyl compound in an alcohol solution may be conducted at a temperature and for a time effective to provide compound Vc. In a more particular embodiment, the reaction may be conducted at a temperature between about 55 and about 60°C for a time between about 1 to 2 hours.
In another embodiment, the alcohol solution comprises sodium alkoxide in absolute alcohol. For example, suitable sodium alkoxides include sodium methoxide, sodium ethoxide sodium isopropoxide and sodium tert-butoxide. For example, suitable absolute alcohols include methanol, ethanol, propanol, butanol, isobutanol and tert-butanol. In particular, the alcohol solution comprises sodium ethoxide in absolute ethanol.
In another embodiment, reacting the compound of formula Vc with a mixture of acid may be conducted at a temperature and for a time effective to provide compound I. In a more particular embodiment, the reaction may be conducted at a temperature between about 70 and about 80°C for a time between about 1 to 2 hours.
In another embodiment, the mixture of acids may be a mixture of acetic and hydrochloric acid.
Minimizing the charge of aluminum chloride may help control any impurities that form during the above process.
Unless specified otherwise within this specification, the nomenclature used in this specification generally follows the examples and rules stated in Nomenclature of Organic Chemistry, Sections A, B, C, D, E, F, and H, Pergamon Press, Oxford, 1979, which is incorporated by references herein for its exemplary chemical structure names and rules on naming chemical structures.
The term "alkyl" used alone or as a suffix or prefix, refers to monovalent straight or branched chain hydrocarbon radicals comprising 1 to about 12 carbon atoms.
Unless otherwise specified, °'alkyl'° generally includes both saturated alkyl and unsaturated alkyl.
The term "cycloalkyl," used alone or as suffix or prefix, refers to a monovalent ring-containing hydrocarbon radical comprising at least 3 up to about 12 carbon atoms.
The term "aryl" used alone or as suffix or prefix, refers to a hydrocarbon radical having one or more polyunsaturated carbon rings having aromatic character, (e.g., 4n + 2 delocalized electrons) and comprising 5 up to about 14 carbon atoms, wherein the radical is located on a carbon of the aromatic ring.
The term "heterocycle" used alone or as a suffix or prefix, refers to a ring-containing structure or molecule having one or more multivalent heteroatoms, independently selected from N, O, P and S, as a part of the ring structure and including at least 3 and up to about 20 atoms in the ring(s). Heterocycle may be saturated or unsaturated, containing one or more double bonds, and heterocycle may contain more than one ring. When a heterocycle contains more than one ring, the rings may be fused or unfused. Fused rings generally refer to at least two rings share two atoms therebetween. Heterocycle may have aromatic character or may not have aromatic character.
The term "alkoxy" used alone or as a suffix or prefix, refers to radicals of the general formula -O-R, wherein -R is selected from a hydrocarbon radical. Exemplary alkoxy includes methoxy, ethoxy, propoxy, isopropoxy, butoxy, t-butoxy, isobutoxy, cyclopropylmethoxy, allyloxy, and propargyloxy.
Halogen includes fluorine, chlorine, bromine and iodine.
_7_ When a first group, structure, or atom is "directly connected" to a second group, structure or atom, at least one atom of the first group, structure or atom forms a chemical bond with at least one atom of the second group, structure or atom.
"Saturated carbon" means a carbon atom in a structure, molecule or group wherein all the bonds connected to this carbon atom are single bond. In other words, there is no double or triple bonds connected to this carbon atom and this carbon atom generally adopts an spa atomic orbital hybridization.
"Unsaturated carbon" means a carbon atom in a structure; molecule or group wherein at least one bond connected to this carbon atom is not a single bond. In other words, there is at least one double or triple bond connected to this carbon atom and this carbon atom generally adopts a sp or sp2 atomic orbital hybridization.
The processes and synthetic methods described hereinthroughout may be carried out with or without a suitable solvent or base. Generally, suitable solvents are solvents which are substantially non-reactive with the starting materials (reactants), the intermediates, or products at the temperatures at which the reactions are carried out, i.e., temperatures which may range from the solvent's freezing temperature to the solvent's boiling temperature.
A given reaction may be carried out in one solvent or a mixture of more than one solvent. Depending on the particular reaction, suitable solvents for a particular work-up following the reaction may be selected. For example, suitable solvents may include water, alcohols, hydrocarbon solvents and halogenated derivatives. In particular, water, dichloromethane, xylene, ethanol and methanol.
Examples P~~eparation of I-(3-bromo-5 fluoro-2-hydroxyphe~yl)ethanone _g_ A mixture of 2-bromo-4-fluorophenol (64.0 kg, 1.00 mol equiv) and acetyl chloride (62.5 kg, 2.39 mol equiv) was stirred and heated at 50-55°C for one hour. Excess acetyl chloride (10.8 kg) was removed by distillation and the residue was cooled to 25-30°C then diluted with dichloromethane (120 L). The mixture was further cooled to 10-15°C and aluminum chloride (51.0 kg, 1.15 mol equiv) was added in two portions. The temperature of the mixture was raised to 130-135°C over one hour during which time dichloromethane (80 L) was removed by distillation. The mixture was maintained at 130-135°C
for one hour, diluted with xylene (250 L) and cooled to 10-15°C. The reaction mixture was added to a solution of 30% w/w hydrochloric acid (25 L) in water (500 L). The layers were separated and the organic phase was extracted with 10% w/w sodium hydroxide solution (300 L). The aqueous extract was cooled to 10-15°C and adjusted to pH 6.8-7.2 with 30% w/w hydrochloric acid (55.0 kg). The solid was filtered off, washed with water (60 L), then with petroleum ether (100 L) and dried at 55-60°C under vacuum. The yield of 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone was 46.0 kg (60%).
P~epa~ation of ethyl ~-bromo-6 fluo~o-4-oxo-4H ch~omehe-2-ca~boxylate A mixture of 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone (46.0 kg, 1.00 mol equiv) and diethyl oxalate (172.0 kg, 6.00 mol equiv) was added to a solution of sodium ethoxide (66.8 kg, 4.9 mol equiv) in absolute ethanol (250 L) at 60°C.
The mixture was stirred at 55-60°C for one hour and ethanol was removed by distillation. The residual mixture was diluted with water (300 L) and the precipitated solid isolated by filtration.
This solid was heated with a mixture of acetic acid (210 L) and 30 w/w hydrochloric acid (55.5 L) at 70-80°C for two hours. After cooling at 25°C, the mixture was diluted with water (150 L and 100 L), then with 12% w/w sodium bicarbonate solution (50 L) and finally methanol (100 L) before drying at 70°C under vacuum. The yield of ethyl 8-bromo-6-fluoro-4-oxo-4H
chromene-2-carboxylate was 38.6 kg (63%).
In another embodiment, reacting the compound of formula Vb with a dicarbonyl compound in an alcohol solution may be conducted at a temperature and for a time effective to provide compound Vc. In a more particular embodiment, the reaction may be conducted at a temperature between about 55 and about 60°C for a time between about 1 to 2 hours.
In another embodiment, the alcohol solution comprises sodium alkoxide in absolute alcohol. For example, suitable sodium alkoxides include sodium methoxide, sodium ethoxide sodium isopropoxide and sodium tert-butoxide. For example, suitable absolute alcohols include methanol, ethanol, propanol, butanol, isobutanol and tert-butanol. In particular, the alcohol solution comprises sodium ethoxide in absolute ethanol.
In another embodiment, reacting the compound of formula Vc with a mixture of acid may be conducted at a temperature and for a time effective to provide compound I. In a more particular embodiment, the reaction may be conducted at a temperature between about 70 and about 80°C for a time between about 1 to 2 hours.
In another embodiment, the mixture of acids may be a mixture of acetic and hydrochloric acid.
Minimizing the charge of aluminum chloride may help control any impurities that form during the above process.
Unless specified otherwise within this specification, the nomenclature used in this specification generally follows the examples and rules stated in Nomenclature of Organic Chemistry, Sections A, B, C, D, E, F, and H, Pergamon Press, Oxford, 1979, which is incorporated by references herein for its exemplary chemical structure names and rules on naming chemical structures.
The term "alkyl" used alone or as a suffix or prefix, refers to monovalent straight or branched chain hydrocarbon radicals comprising 1 to about 12 carbon atoms.
Unless otherwise specified, °'alkyl'° generally includes both saturated alkyl and unsaturated alkyl.
The term "cycloalkyl," used alone or as suffix or prefix, refers to a monovalent ring-containing hydrocarbon radical comprising at least 3 up to about 12 carbon atoms.
The term "aryl" used alone or as suffix or prefix, refers to a hydrocarbon radical having one or more polyunsaturated carbon rings having aromatic character, (e.g., 4n + 2 delocalized electrons) and comprising 5 up to about 14 carbon atoms, wherein the radical is located on a carbon of the aromatic ring.
The term "heterocycle" used alone or as a suffix or prefix, refers to a ring-containing structure or molecule having one or more multivalent heteroatoms, independently selected from N, O, P and S, as a part of the ring structure and including at least 3 and up to about 20 atoms in the ring(s). Heterocycle may be saturated or unsaturated, containing one or more double bonds, and heterocycle may contain more than one ring. When a heterocycle contains more than one ring, the rings may be fused or unfused. Fused rings generally refer to at least two rings share two atoms therebetween. Heterocycle may have aromatic character or may not have aromatic character.
The term "alkoxy" used alone or as a suffix or prefix, refers to radicals of the general formula -O-R, wherein -R is selected from a hydrocarbon radical. Exemplary alkoxy includes methoxy, ethoxy, propoxy, isopropoxy, butoxy, t-butoxy, isobutoxy, cyclopropylmethoxy, allyloxy, and propargyloxy.
Halogen includes fluorine, chlorine, bromine and iodine.
_7_ When a first group, structure, or atom is "directly connected" to a second group, structure or atom, at least one atom of the first group, structure or atom forms a chemical bond with at least one atom of the second group, structure or atom.
"Saturated carbon" means a carbon atom in a structure, molecule or group wherein all the bonds connected to this carbon atom are single bond. In other words, there is no double or triple bonds connected to this carbon atom and this carbon atom generally adopts an spa atomic orbital hybridization.
"Unsaturated carbon" means a carbon atom in a structure; molecule or group wherein at least one bond connected to this carbon atom is not a single bond. In other words, there is at least one double or triple bond connected to this carbon atom and this carbon atom generally adopts a sp or sp2 atomic orbital hybridization.
The processes and synthetic methods described hereinthroughout may be carried out with or without a suitable solvent or base. Generally, suitable solvents are solvents which are substantially non-reactive with the starting materials (reactants), the intermediates, or products at the temperatures at which the reactions are carried out, i.e., temperatures which may range from the solvent's freezing temperature to the solvent's boiling temperature.
A given reaction may be carried out in one solvent or a mixture of more than one solvent. Depending on the particular reaction, suitable solvents for a particular work-up following the reaction may be selected. For example, suitable solvents may include water, alcohols, hydrocarbon solvents and halogenated derivatives. In particular, water, dichloromethane, xylene, ethanol and methanol.
Examples P~~eparation of I-(3-bromo-5 fluoro-2-hydroxyphe~yl)ethanone _g_ A mixture of 2-bromo-4-fluorophenol (64.0 kg, 1.00 mol equiv) and acetyl chloride (62.5 kg, 2.39 mol equiv) was stirred and heated at 50-55°C for one hour. Excess acetyl chloride (10.8 kg) was removed by distillation and the residue was cooled to 25-30°C then diluted with dichloromethane (120 L). The mixture was further cooled to 10-15°C and aluminum chloride (51.0 kg, 1.15 mol equiv) was added in two portions. The temperature of the mixture was raised to 130-135°C over one hour during which time dichloromethane (80 L) was removed by distillation. The mixture was maintained at 130-135°C
for one hour, diluted with xylene (250 L) and cooled to 10-15°C. The reaction mixture was added to a solution of 30% w/w hydrochloric acid (25 L) in water (500 L). The layers were separated and the organic phase was extracted with 10% w/w sodium hydroxide solution (300 L). The aqueous extract was cooled to 10-15°C and adjusted to pH 6.8-7.2 with 30% w/w hydrochloric acid (55.0 kg). The solid was filtered off, washed with water (60 L), then with petroleum ether (100 L) and dried at 55-60°C under vacuum. The yield of 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone was 46.0 kg (60%).
P~epa~ation of ethyl ~-bromo-6 fluo~o-4-oxo-4H ch~omehe-2-ca~boxylate A mixture of 1-(3-bromo-5-fluoro-2-hydroxyphenyl)ethanone (46.0 kg, 1.00 mol equiv) and diethyl oxalate (172.0 kg, 6.00 mol equiv) was added to a solution of sodium ethoxide (66.8 kg, 4.9 mol equiv) in absolute ethanol (250 L) at 60°C.
The mixture was stirred at 55-60°C for one hour and ethanol was removed by distillation. The residual mixture was diluted with water (300 L) and the precipitated solid isolated by filtration.
This solid was heated with a mixture of acetic acid (210 L) and 30 w/w hydrochloric acid (55.5 L) at 70-80°C for two hours. After cooling at 25°C, the mixture was diluted with water (150 L and 100 L), then with 12% w/w sodium bicarbonate solution (50 L) and finally methanol (100 L) before drying at 70°C under vacuum. The yield of ethyl 8-bromo-6-fluoro-4-oxo-4H
chromene-2-carboxylate was 38.6 kg (63%).
Claims (7)
1. A process of preparing a compound of formula I:
wherein R1 is selected from H, C1-10alkyl, halogen, amino, C1-6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, C1-6alkyl, halogen, hydroxy, amino, C1-6alkyl-amino, C1-6alkyl-carbonyl, C1-6alkyl-oxy and C1-6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising:
A) heating a mixture of a compound of formula Va:
and acetylating agent in the presence of a Lewis acid catalyst at a temperature and for a time effective to give compounds of formula Vb:
B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc:
C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula I.
wherein R1 is selected from H, C1-10alkyl, halogen, amino, C1-6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, C1-6alkyl, halogen, hydroxy, amino, C1-6alkyl-amino, C1-6alkyl-carbonyl, C1-6alkyl-oxy and C1-6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising:
A) heating a mixture of a compound of formula Va:
and acetylating agent in the presence of a Lewis acid catalyst at a temperature and for a time effective to give compounds of formula Vb:
B) combining the compounds of formula Vb and a dicarbonyl compound to an alcohol solution at a temperature and for a time effective to give compounds of formula Vc:
C) heating the compound of formula Vc with a mixture of acids at a temperature and for a time effective to give compounds of formula I.
2. A process according to claim 1, wherein R1 is, independently, hydrogen or fluoro.
3. A process according to claim 1, wherein R2 is, independently, H, C1-6alkyl, C1-6alkyl-oxy or hydroxy.
4. A process according to claim 1, wherein L is bromo.
5. A process of preparing a compound of formula I:
wherein R1 is selected from H, C1-10alkyl, halogen, amino, C1-6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, C1-6alkyl, halogen, hydroxy, amino, C1-6alkyl-ammo, C1-6alkyl-carbonyl, C1-6alkyl-oxy and C1-6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising:
A) heating a mixture of a compound of formula Va:
and acetyl chloride in the presence of either aluminum chloride or zirconium tetrachloride at a temperature and for a time effective to give compounds of formula Vb:
B) combining the compounds of formula Vb and diethyl oxalate to a solution of sodium ethoxide in absolute ethanol at a temperature and for a time effective to give compounds of formula Vc:
C) heating the compound of formula Vc with a mixture of acetic acid and hydrochloric acid at a temperature and for a time effective to give compounds of formula I.
wherein R1 is selected from H, C1-10alkyl, halogen, amino, C1-6alkyl-oxy, or hydroxy;
L is a displaceable group selected from bromo, chloro, fluoro or iodo; and R2 is selected from H, C1-6alkyl, halogen, hydroxy, amino, C1-6alkyl-ammo, C1-6alkyl-carbonyl, C1-6alkyl-oxy and C1-6alkyl-oxycarbonyl optionally substituted by one or more groups selected from halogen, amino and hydroxy;
comprising:
A) heating a mixture of a compound of formula Va:
and acetyl chloride in the presence of either aluminum chloride or zirconium tetrachloride at a temperature and for a time effective to give compounds of formula Vb:
B) combining the compounds of formula Vb and diethyl oxalate to a solution of sodium ethoxide in absolute ethanol at a temperature and for a time effective to give compounds of formula Vc:
C) heating the compound of formula Vc with a mixture of acetic acid and hydrochloric acid at a temperature and for a time effective to give compounds of formula I.
6. A process according to claim 5, wherein R1 is, independently, hydrogen or fluoro.
7. A process according to claim 5, wherein R2 is, independently, H, C1-6alkyl, C1-6alkyl-oxy or hydroxy.
A process according to claim 5, wherein L, is bromo.
A process according to claim 5, wherein L, is bromo.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400786-0 | 2004-03-25 | ||
| SE0400786A SE0400786D0 (en) | 2004-03-25 | 2004-03-25 | Novel Process for the preparation of a chromone intermediate |
| PCT/SE2005/000415 WO2005092879A1 (en) | 2004-03-25 | 2005-03-22 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2561160A1 true CA2561160A1 (en) | 2005-10-06 |
Family
ID=32067537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002561160A Abandoned CA2561160A1 (en) | 2004-03-25 | 2005-03-22 | Novel process |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1732914A1 (en) |
| JP (1) | JP2007530535A (en) |
| KR (1) | KR20060129496A (en) |
| CN (1) | CN1953970A (en) |
| AU (1) | AU2005226605A1 (en) |
| BR (1) | BRPI0509020A (en) |
| CA (1) | CA2561160A1 (en) |
| IL (1) | IL177963A0 (en) |
| NO (1) | NO20064862L (en) |
| RU (1) | RU2006135484A (en) |
| SE (1) | SE0400786D0 (en) |
| WO (1) | WO2005092879A1 (en) |
| ZA (1) | ZA200607553B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05255172A (en) * | 1992-03-16 | 1993-10-05 | Shell Internatl Res Maatschappij Bv | Manufacture of 3,6-dichloro-2-hydroxyacetophenone |
| JPH07291983A (en) * | 1993-05-18 | 1995-11-07 | Takeda Chem Ind Ltd | Benzopyran derivative and medicine containing the same |
| DE69412538T2 (en) * | 1993-05-18 | 1998-12-24 | Takeda Chemical Industries, Ltd., Osaka | Benzopyran derivatives and their use |
| US6756403B2 (en) * | 2000-06-02 | 2004-06-29 | Eli Lilly And Company | Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
-
2004
- 2004-03-25 SE SE0400786A patent/SE0400786D0/en unknown
-
2005
- 2005-03-22 CA CA002561160A patent/CA2561160A1/en not_active Abandoned
- 2005-03-22 JP JP2007504914A patent/JP2007530535A/en active Pending
- 2005-03-22 KR KR1020067019560A patent/KR20060129496A/en not_active Withdrawn
- 2005-03-22 RU RU2006135484/04A patent/RU2006135484A/en not_active Application Discontinuation
- 2005-03-22 BR BRPI0509020-2A patent/BRPI0509020A/en not_active IP Right Cessation
- 2005-03-22 EP EP05722256A patent/EP1732914A1/en not_active Withdrawn
- 2005-03-22 CN CNA2005800096380A patent/CN1953970A/en active Pending
- 2005-03-22 WO PCT/SE2005/000415 patent/WO2005092879A1/en not_active Ceased
- 2005-03-22 AU AU2005226605A patent/AU2005226605A1/en not_active Abandoned
-
2006
- 2006-09-07 IL IL177963A patent/IL177963A0/en unknown
- 2006-09-08 ZA ZA200607553A patent/ZA200607553B/en unknown
- 2006-10-25 NO NO20064862A patent/NO20064862L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20064862L (en) | 2006-12-21 |
| AU2005226605A1 (en) | 2005-10-06 |
| ZA200607553B (en) | 2008-09-25 |
| JP2007530535A (en) | 2007-11-01 |
| WO2005092879A1 (en) | 2005-10-06 |
| WO2005092879A8 (en) | 2006-10-19 |
| KR20060129496A (en) | 2006-12-15 |
| SE0400786D0 (en) | 2004-03-25 |
| RU2006135484A (en) | 2008-05-10 |
| IL177963A0 (en) | 2006-12-31 |
| BRPI0509020A (en) | 2007-08-07 |
| CN1953970A (en) | 2007-04-25 |
| EP1732914A1 (en) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG187565A1 (en) | Process for preparing benzofuran derivatives substituted at position 5 | |
| CN103958467B (en) | Process for preparing 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and its precursors | |
| CN108623456A (en) | The preparation method of butylphenyl phthaleine and its pharmaceutical intermediate | |
| WO2016078505A1 (en) | Preparation method of fluorene ethyl ketone derivative | |
| CN107879992A (en) | A kind of preparation method of (base of 1 methyl 1H [1,2,4] triazole 3) methanol | |
| WO2018010651A1 (en) | Method for manufacturing obeticholic acid and intermediate thereof | |
| JP2018043989A (en) | Method for producing blonanserin | |
| CA2561160A1 (en) | Novel process | |
| CN110734364B (en) | Synthesis method of 1- (4-chlorphenyl) -2-cyclopropyl-1-acetone | |
| JP5463051B2 (en) | Method for producing 1,4-dihydropyridine derivative | |
| JP6256469B2 (en) | Process for the preparation of spiro [2.5] octane-5,7-dione | |
| MXPA06010734A (en) | Novel process | |
| CN117700390A (en) | Preparation method of benzopyrene south methane sulfonamide derivative | |
| WO2025022637A1 (en) | Method for producing cyclized product by cyclization reaction involving dehydration condensation of carboxylic acid ester derivative, and method for producing 1,3,4-substituted-pyrazole-5-carboxylic acid ester | |
| JPH10265433A (en) | Method for producing phenylpropionic acid derivative | |
| WO2025173788A1 (en) | Method for producing 3-hydroxybiphenyl compound and derivative thereof | |
| KR100408431B1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one or pharmaceutically acceptable salts thereof | |
| JP3864763B2 (en) | 3-halo-2-hydrazono-1-hydroxyiminopropane derivative and process for producing the same | |
| EP2365746B1 (en) | Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids | |
| CN121039088A (en) | Process for producing 3-hydroxybiphenyl compound and derivative thereof | |
| JP3953225B2 (en) | Method for producing quinoline derivative | |
| RU2277083C1 (en) | Method for preparing 5,8-dihydroxy-2,6,7-trimethoxy-3-ethyl-1,4-naphthoquinone | |
| US20070219372A1 (en) | Novel Amination Process | |
| JPH041736B2 (en) | ||
| KR20070011824A (en) | Method for preparing dibenzothione derivatives and intermediates thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20100322 |